- Home
- BCTX vs MTR Comparison
BCTX vs MTR Comparison
Compare BCTX & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- MTR
- Stock Information
- Founded
- BCTX 2014
- MTR 1979
- Country
- BCTX Canada
- MTR United States
- Employees
- BCTX N/A
- MTR N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- MTR Oil & Gas Production
- Sector
- BCTX Health Care
- MTR Energy
- Exchange
- BCTX Nasdaq
- MTR Nasdaq
- Market Cap
- BCTX 16.1M
- MTR 11.7M
- IPO Year
- BCTX N/A
- MTR N/A
- Fundamental
- Price
- BCTX $3.18
- MTR $5.30
- Analyst Decision
- BCTX Strong Buy
- MTR
- Analyst Count
- BCTX 1
- MTR 0
- Target Price
- BCTX $32.00
- MTR N/A
- AVG Volume (30 Days)
- BCTX 3.7M
- MTR 5.2K
- Earning Date
- BCTX 06-13-2025
- MTR 01-01-0001
- Dividend Yield
- BCTX N/A
- MTR 3.55%
- EPS Growth
- BCTX N/A
- MTR N/A
- EPS
- BCTX N/A
- MTR 0.25
- Revenue
- BCTX N/A
- MTR $731,355.00
- Revenue This Year
- BCTX N/A
- MTR N/A
- Revenue Next Year
- BCTX N/A
- MTR N/A
- P/E Ratio
- BCTX N/A
- MTR $20.85
- Revenue Growth
- BCTX N/A
- MTR N/A
- 52 Week Low
- BCTX $0.35
- MTR $4.84
- 52 Week High
- BCTX $9.82
- MTR $9.98
- Technical
- Relative Strength Index (RSI)
- BCTX 37.13
- MTR 44.45
- Support Level
- BCTX $4.04
- MTR $5.18
- Resistance Level
- BCTX $9.82
- MTR $5.32
- Average True Range (ATR)
- BCTX 0.75
- MTR 0.10
- MACD
- BCTX -0.22
- MTR 0.04
- Stochastic Oscillator
- BCTX 1.34
- MTR 48.10
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.